Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) has shared an update.
Epsilon Healthcare Limited has received updated Certificates of GMP Compliance from the Therapeutic Goods Administration for its subsidiary, Epsilon Pharma Pty Ltd. These certificates cover Domestic and Mutual Recognition Agreement pathways for the EU and UK, valid until June 2026. This certification supports Epsilon’s growth agenda in contract development and manufacturing, enhancing its international sales pipeline and validating its quality systems. The company is now better positioned to expand exports into regulated markets, reinforcing its commitment to GMP-compliant pharmaceutical manufacturing and international regulatory alignment.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited (ASX: EPN) is an Australian-based, globally active healthcare organization. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing, and pharmacy dispensing and information services.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
For an in-depth examination of EPN stock, go to TipRanks’ Overview page.